ArticleFrontiers in medicine2025

Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial.

Shuo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.